BioInitials AG develops non-invasive medical devices and a monitoring platform that analyze saliva biomarkers to assess health status, disease risk factors and disease progression. Biomarker data is combined with other inputs and evaluated using artificial intelligence; project work has included sensor units measuring saliva pH, glucose and impedance.
AI-generated
Offering
Products & services
Industry:Medical Technology IndustryPharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Non-invasive medical devices and a platform for health monitoring based on salivary biomarkers; evaluated with artificial intelligence for early detection and disease progression prediction.
Saliva-based biomarker diagnostics
Analysis of salivary biomarkers for early diagnosis and monitoring of chronic diseases such as asthma, periodontitis, diabetes and cardiovascular conditions.
Development of non-invasive medical devices
Development of non-invasive medical devices such as a toothbrush with sensor technology to measure salivary parameters and monitor health.
Knowledge
No knowledge articles yet
Once BioInitials AG has claimed this profile, we'll publish editorial articles and case studies here together.